Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Antimicrobial stewardship

Philip Howard takes up presidency of British Society for Antimicrobial Chemotherapy

Pharmacist Philip Howard will serve as the president of the British Society for Antimicrobial Chemotherapy until 2021.

Philip Howard, president of the BSAC

Source: Courtesy, Philip Howard

Philip Howard (right, pictured with the previous president Dilip Nathwani) has taken up his post as president of the British Society of Antimicrobial Chemotherapy

Philip Howard FRPharmS has taken up his post as president of the British Society for Antimicrobial Chemotherapy (BSAC), having been voted in as president-elect one year ago at the associations’ 2017 annual general meeting. The occasion marks the first time in the association’s 45-year history that a pharmacist has held the post.

Howard is consultant antimicrobial pharmacist at Leeds Teaching Hospitals NHS Trust and a Royal Pharmaceutical Society (RPS) spokesperson on antimicrobials, as well as being a member of the RPS antimicrobial expert advisory group. In his new capacity, he will lead the BSAC’s efforts to share understanding of antimicrobial medicines, and to set global standards for antimicrobial susceptibility testing and medicines use.

“The appointment of a pharmacist as president of the BSAC is major step forward for the profession,” Howard said. “It recognises the significant contribution that pharmacy has made for more than a decade in developing antimicrobial stewardship in partnership with doctors.

“The BSAC is a global player and will provide a platform to highlight both the leadership and delivery roles that pharmacy and other professions outside of medicine can play. Antimicrobial resistance will always remain the biggest risk to modern medicine, and so it is essential that a truly multi-professional approach is adopted worldwide.”

Howard will serve as the BSAC president until 2021.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204567

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Philip Howard, president of the BSAC

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.